NCT05814172

Brief Summary

Hip fracture has a serious impact on the quality of life and even the survival of older adults. The multidisciplinary management of hip fracture has been shown to be effective in improving patient outcome and cost-effective in international studies. As geriatricians and members of a multi-disciplinary team(MDT), we are aware of various scores in predicting the 1-year mortality risk in hospitalized older adults with multimorbidity. However, given the need for a deeper understanding of the preoperative status of elderly patients who were suffering from pain, tension, anxiety, delirium,etc., we hope to explore a simple, quick, objective, and accurate method for assessing the status of elderly patients with hip fractures to predict their survival risk.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
303

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

October 31, 2023

Status Verified

March 1, 2023

Enrollment Period

1 month

First QC Date

March 19, 2023

Last Update Submit

October 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality

    After discharge, all enrolled patients were followed-up in an outpatients setting. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Outcomes were recorded.

    Calculated from the time of discharge, each patient was followed up 1 year, all-cause death in 1 year after discharge was counted.

Study Arms (2)

Death by 1 y

patients who dieded within 1-year after discharge due to hip fracture surgery

Other: no intervention

Alive at 1 y

patients who survived 1-year after discharge due to hip fracture surgery

Other: no intervention

Interventions

no intervention

Alive at 1 yDeath by 1 y

Eligibility Criteria

Age65 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Older adults with unilateral hip fractures who received surgical treatment in our hospital from January 2014 to December 2021 were enrolled.

You may qualify if:

  • patients aged ≧65 years old;
  • patients diagnosed with hip fracture, including femoral neck fracture, femoral intertrochanteric fracture, and femoral subtrochanteric fracture;
  • patients whose injury was within 21 days of presentation.

You may not qualify if:

  • patients aged \<65 years old;
  • patients with pathological fractures due to tumor metastasis or infection or inherited bone disorder;
  • patients with avascular necrosis of femoral head;
  • patients with periprosthetic fractures;
  • old fracture patients treated more than 21 days from injury;
  • patients with severe trauma or fracture in other parts;
  • patients and their families who could not bear the surgical risk and are unwilling to receive surgical treatment;
  • patients died in hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, 100730, China

RECRUITING

Study Officials

  • QI LIU

    Beijing Tongren Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2023

First Posted

April 14, 2023

Study Start

October 1, 2023

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

October 31, 2023

Record last verified: 2023-03

Locations